Logo image of IONM

ASSURE HOLDINGS CORP (IONM) Stock Fundamental Analysis

NASDAQ:IONM - Nasdaq - US04625J3032 - Common Stock - Currency: USD

2.43  -0.32 (-11.64%)

After market: 1.85 -0.58 (-23.87%)

Fundamental Rating

2

Overall IONM gets a fundamental rating of 2 out of 10. We evaluated IONM against 108 industry peers in the Health Care Providers & Services industry. IONM has a bad profitability rating. Also its financial health evaluation is rather negative. IONM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IONM had negative earnings in the past year.
In the past year IONM has reported a negative cash flow from operations.
In multiple years IONM reported negative net income over the last 5 years.
In the past 5 years IONM always reported negative operating cash flow.
IONM Yearly Net Income VS EBIT VS OCF VS FCFIONM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -251.76%, IONM is doing worse than 96.55% of the companies in the same industry.
Industry RankSector Rank
ROA -251.76%
ROE N/A
ROIC N/A
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
IONM Yearly ROA, ROE, ROICIONM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IONM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IONM Yearly Profit, Operating, Gross MarginsIONM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

IONM does not have a ROIC to compare to the WACC, probably because it is not profitable.
IONM has more shares outstanding than it did 1 year ago.
IONM has a worse debt/assets ratio than last year.
IONM Yearly Shares OutstandingIONM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 200K 400K 600K 800K 1M
IONM Yearly Total Debt VS Total AssetsIONM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

IONM has an Altman-Z score of -11.27. This is a bad value and indicates that IONM is not financially healthy and even has some risk of bankruptcy.
IONM has a Altman-Z score of -11.27. This is amonst the worse of the industry: IONM underperforms 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.27
ROIC/WACCN/A
WACC8.41%
IONM Yearly LT Debt VS Equity VS FCFIONM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.50 indicates that IONM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.50, IONM is in line with its industry, outperforming 56.90% of the companies in the same industry.
A Quick Ratio of 1.50 indicates that IONM should not have too much problems paying its short term obligations.
IONM has a better Quick ratio (1.50) than 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
IONM Yearly Current Assets VS Current LiabilitesIONM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

IONM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6836.67%.
IONM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.38%.
IONM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.02% yearly.
EPS 1Y (TTM)-6836.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.62%
Revenue 1Y (TTM)-62.38%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Sales Q2Q%-99.72%

3.2 Future

The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 35.16% on average over the next years. This is a very strong growth
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IONM Yearly Revenue VS EstimatesIONM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
IONM Yearly EPS VS EstimatesIONM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IONM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IONM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IONM Price Earnings VS Forward Price EarningsIONM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IONM Per share dataIONM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

IONM's earnings are expected to grow with 24.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.18%
EPS Next 3Y24.9%

More info and screens

0

5. Dividend

5.1 Amount

IONM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASSURE HOLDINGS CORP

NASDAQ:IONM (7/23/2024, 8:17:36 PM)

After market: 1.85 -0.58 (-23.87%)

2.43

-0.32 (-11.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-07 2024-06-07/amc
Earnings (Next)08-12 2024-08-12/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners126.89%
Ins Owner Change0%
Market Cap1.43M
Analysts82.86
Price Target4.08 (67.9%)
Short Float %0.02%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-210.59%
Min EPS beat(2)-435.95%
Max EPS beat(2)14.77%
EPS beat(4)1
Avg EPS beat(4)-601.37%
Min EPS beat(4)-1923.47%
Max EPS beat(4)14.77%
EPS beat(8)1
Avg EPS beat(8)-334.84%
EPS beat(12)2
Avg EPS beat(12)-279.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.49%
Min Revenue beat(2)-84.04%
Max Revenue beat(2)-70.94%
Revenue beat(4)0
Avg Revenue beat(4)-73.34%
Min Revenue beat(4)-122.72%
Max Revenue beat(4)-15.67%
Revenue beat(8)1
Avg Revenue beat(8)-51.15%
Revenue beat(12)3
Avg Revenue beat(12)-32.93%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-41.62
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-12.95
FCFYN/A
OCF(TTM)-12.86
OCFYN/A
SpS6.05
BVpS-10.29
TBVpS-10.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -251.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.19%
ROA(5y)-30.71%
ROE(3y)-212.76%
ROE(5y)-111.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -11.27
F-Score1
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)11.22%
Cap/Depr(5y)23.22%
Cap/Sales(3y)3.27%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6836.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.62%
EPS Next Y95.91%
EPS Next 2Y41.18%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.38%
Revenue growth 3Y-14.76%
Revenue growth 5Y-7.02%
Sales Q2Q%-99.72%
Revenue Next Year13.65%
Revenue Next 2Y26.35%
Revenue Next 3Y35.16%
Revenue Next 5YN/A
EBIT growth 1Y-156.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.04%
EBIT Next 3Y32.63%
EBIT Next 5YN/A
FCF growth 1Y25.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.35%
OCF growth 3YN/A
OCF growth 5YN/A